ArticleMedical oncology (Northwood, London, England)2026
Overcoming cordycepin limitations with SLNs-based nanoformulation: formulation development and cytotoxicity evaluation against human breast cancer cells.
Saumyadeep Bora et al.PubMed ↗Publisher ↗
No numbers read from the abstract.